Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: MAPP BIOPHARMACEUTICAL, INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2021-09-30 to 2024-03-01
Current total value of award: $767803.19
Description: BIOPHARMACEUTICAL CELL CREATION